{
    "clinical_study": {
        "@rank": "56853", 
        "arm_group": [
            {
                "arm_group_label": "PureMoist - Biotrue", 
                "arm_group_type": "Other", 
                "description": "Opti-Free\u00ae PureMoist\u00ae MPDS used first, followed by Biotrue\u2122 MPS. Each product used as indicated for 30 days with participant's habitual contact lenses."
            }, 
            {
                "arm_group_label": "Biotrue - PureMoist", 
                "arm_group_type": "Other", 
                "description": "Biotrue\u2122 MPS used first, followed by Opti-Free\u00ae PureMoist\u00ae MPDS. Each product used as indicated for 30 days with participant's habitual contact lenses."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study was to evaluate the performance of Opti-Free\u00ae PureMoist\u00ae\n      Multi-Purpose Disinfecting Solution (MPDS) compared to Biotrue\u2122 Multipurpose Solution (MPS)\n      in silicone hydrogel contact lens wearers."
        }, 
        "brief_title": "Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 1", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "Opti-Free\u00ae PureMoist\u00ae MPDS and Biotrue\u2122 MPS used during Period 1 and Period 2 in randomized order in crossover assignment.", 
                        "title": "PureMoist / Biotrue"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "198"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "11.48", 
                                            "@value": "31.7"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "151"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "47"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }
                    ]
                }, 
                "population": "This analysis population includes all participants who were exposed to a study regimen (test or control)."
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "Sponsor reserves the right of prior review of any publication or presentation of information related to the study."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Corneal staining in both eyes was assessed during slit lamp examination using flourescein dye. Each of five corneal regions (central, nasal, temporal, inferior, and superior) was graded on a scale from 0 (none) to 4 (patch). The corneal fluorescein staining score was calculated as the total of the five regions. The score ranged from 0 (no staining in any region) to 20 (patch staining in all five regions). The corneal staining of the worse eye was analyzed.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Opti-Free\u00ae PureMoist\u00ae MPDS used during Period 1 or Period 2 for 30 days with participant's habitual contact lenses.", 
                                    "title": "PureMoist"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Biotrue\u2122 MPS used during Period 1 or Period 2 for 30 days with participant's habitual contact lenses.", 
                                    "title": "Biotrue"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "192"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "192"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.30", 
                                                        "@value": "1.9"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "2.62", 
                                                        "@value": "2.8"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Corneal staining in both eyes was assessed during slit lamp examination using flourescein dye. Each of five corneal regions (central, nasal, temporal, inferior, and superior) was graded on a scale from 0 (none) to 4 (patch). The corneal fluorescein staining score was calculated as the total of the five regions. The score ranged from 0 (no staining in any region) to 20 (patch staining in all five regions). The corneal staining of the worse eye was analyzed.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Corneal Staining", 
                                    "units": "Units on a scale"
                                }
                            ]
                        }, 
                        "population": "This analysis population group includes all participants who were exposed to both treatment regimens.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 30", 
                        "title": "Corneal Staining", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Corneal staining in both eyes was assessed during slit lamp examination using flourescein dye. Each of five corneal regions (central, nasal, temporal, inferior, and superior) was graded on a scale from 0 (none) to 4 (patch). The corneal fluorescein staining score was calculated as the total of the five regions. The score ranged from 0 (no staining in any region) to 20 (patch staining in all five regions). The corneal staining of the worse eye was analyzed.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Opti-Free\u00ae PureMoist\u00ae MPDS used during Period 1 or Period 2 for 30 days with participant's habitual contact lenses.", 
                                    "title": "PureMoist"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Biotrue\u2122 MPS used during Period 1 or Period 2 for 30 days with participant's habitual contact lenses.", 
                                    "title": "Biotrue"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "192"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "192"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.59", 
                                                        "@value": "0.7"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "2.91", 
                                                        "@value": "1.6"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Corneal staining in both eyes was assessed during slit lamp examination using flourescein dye. Each of five corneal regions (central, nasal, temporal, inferior, and superior) was graded on a scale from 0 (none) to 4 (patch). The corneal fluorescein staining score was calculated as the total of the five regions. The score ranged from 0 (no staining in any region) to 20 (patch staining in all five regions). The corneal staining of the worse eye was analyzed.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Change From Baseline in Corneal Staining at Day 30", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Baseline (Day 0), Day 30", 
                        "title": "Change From Baseline in Corneal Staining at Day 30", 
                        "type": "Primary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Opti-Free\u00ae PureMoist\u00ae MPDS, followed by Biotrue\u2122 MPS. Each product used as indicated for 30 days with participant's habitual contact lenses.", 
                            "title": "PureMoist - Biotrue"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Biotrue\u2122 MPS, followed by Opti-Free\u00ae PureMoist\u00ae MPDS. Each product used as indicated for 30 days with participant's habitual contact lenses.", 
                            "title": "Biotrue - PureMoist"
                        }
                    ]
                }, 
                "period_list": {
                    "period": [
                        {
                            "drop_withdraw_reason_list": {
                                "drop_withdraw_reason": [
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "Adverse Event"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "Noncompliance"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "Withdrawal by Subject"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "Lost to Follow-up"
                                    }
                                ]
                            }, 
                            "milestone_list": {
                                "milestone": [
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "99", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "99", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "STARTED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "95", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "98", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "COMPLETED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "4", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "NOT COMPLETED"
                                    }
                                ]
                            }, 
                            "title": "Period 1, First 30 Days"
                        }, 
                        {
                            "drop_withdraw_reason_list": {
                                "drop_withdraw_reason": {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Adverse Event"
                                }
                            }, 
                            "milestone_list": {
                                "milestone": [
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "95", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "98", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "STARTED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "94", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "98", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "COMPLETED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "NOT COMPLETED"
                                    }
                                ]
                            }, 
                            "title": "Period 2, Second 30 Days"
                        }
                    ]
                }, 
                "pre_assignment_details": "Of the 207 enrolled, 9 participants were exited as screen failures prior to randomization. This reporting group includes all randomized participants who were exposed to a study regimen (test or control) (198).", 
                "recruitment_details": "Participants were recruited from 5 study centers located in the US, 3 study centers located in the UK, and 2 study centers located in Germany."
            }, 
            "point_of_contact": {
                "email": "alcon.medinfo@alcon.com", 
                "name_or_title": "Jessie Lemp, GMA Brand Lead", 
                "organization": "Alcon Research, Ltd.", 
                "phone": "1-888-451-3937"
            }
        }, 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Myopia", 
            "Hyperopia", 
            "Contact Lens Comfort"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hyperopia", 
                "Myopia"
            ]
        }, 
        "detailed_description": {
            "textblock": "In this 2-period crossover study, eligible participants were randomized to either Opti-Free\u00ae\n      PureMoist\u00ae Multi-Purpose Disinfecting Solution or Biotrue\u2122 Multipurpose Solution in Period 1\n      for use with their habitual contact lenses, after which they switched to the alternate\n      solution in Period 2. Each period was 30 days in length. A 2-day washout period during which\n      participants refrained from using a multi-purpose contact lens solution preceded Period 1\n      and Period 2."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Wear single vision sphere silicone hydrogel contact lenses (CooperVision\u2122 Biofinity\u00ae,\n             Alcon\u00ae Air Optix\u00ae Aqua, Bausch+Lomb\u00ae PureVision\u2122 or ACUVUE\u00ae Oasys\u2122)  on a daily wear\n             basis (a minimum of 8 hours per day, 5 days a week) for at least one month prior to\n             Visit 1;\n\n          -  Willing to wear lenses on a daily wear basis (a minimum of 8 hours per day, 5 days a\n             week) for the duration of the study, and wear lenses for 16 hours on two days during\n             the study;\n\n          -  Must have habitually used a Biguanide preserved multi-purpose solution (other than\n             Biotrue) for at least 30 days prior to Visit 1;\n\n          -  Vision correctable to 20/30 Snellen (feet) or better in each eye at distance with\n             pre-study contact lenses at Visit 1;\n\n          -  Have access, capability and willingness to review and answer text messages;\n\n          -  Read, sign, and date IRB/IEC approved informed consent and privacy document before\n             enrollment;\n\n          -  Willing to follow the study procedures and visit schedule;\n\n          -  Other protocol-defined inclusion criteria may apply.\n\n        Exclusion Criteria:\n\n          -  Need to wear lenses on an extended wear (i.e. overnight) basis during the study;\n\n          -  Known sensitivity or intolerance to Biguanide, polyquaternium-1 (POLYQUAD), or ALDOX\n             preserved lens care products;\n\n          -  Monocular (only one eye with functional vision) or fit with only one lens;\n\n          -  Wearing toric or multifocal contact lenses or fit with monovision;\n\n          -  Use of additional lens care products other than a Biguanide preserved multipurpose\n             solution such as daily or enzyme cleaners within the one week prior to Visit 1;\n\n          -  Use of topical ocular over-the-counter (OTC) or prescribed topical ocular\n             medications, with the exception of rewetting drops, within 7 days prior to Visit 1;\n\n          -  Abnormal ocular condition observed during the Visit 1 slit-lamp examination;\n\n          -  Current or history of ocular infections or severe inflammation within 6 months prior\n             to Visit 1;\n\n          -  Ocular surgery within the 12 months prior to Visit 1;\n\n          -  Participation in any other clinical trial within 30 days of enrollment;\n\n          -  Other protocol-defined exclusion criteria may apply."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "207", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 10, 2012", 
        "firstreceived_results_date": "March 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01684033", 
            "org_study_id": "M-12-038", 
            "secondary_id": "1941/ALC"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "PureMoist - Biotrue", 
                    "Biotrue - PureMoist"
                ], 
                "intervention_name": "Opti-Free\u00ae PureMoist\u00ae MPDS", 
                "intervention_type": "Device", 
                "other_name": "OPTI-FREE\u00ae PureMoist\u2122"
            }, 
            {
                "arm_group_label": [
                    "PureMoist - Biotrue", 
                    "Biotrue - PureMoist"
                ], 
                "intervention_name": "Biotrue\u2122 MPS", 
                "intervention_type": "Device", 
                "other_name": "Biotrue\u2122"
            }, 
            {
                "arm_group_label": [
                    "PureMoist - Biotrue", 
                    "Biotrue - PureMoist"
                ], 
                "description": "Silicone hydrogel contact lenses per participant's habitual brand, prescription, and replacement schedule worn on a daily wear basis for at least 8 hours a day, 5 days a week for the duration of the study. During the washout period, the contact lenses were worn on a daily disposable basis.", 
                "intervention_name": "Habitual contact lenses", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "multi-purpose solution", 
            "silicone hydrogel", 
            "contact lenses", 
            "comfort", 
            "Opti-Free", 
            "Biotrue"
        ], 
        "lastchanged_date": "March 12, 2014", 
        "number_of_arms": "2", 
        "official_title": "Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 1", 
        "overall_official": {
            "affiliation": "Alcon Research", 
            "last_name": "Jessie Lemp, MS", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United Kingdom: Research Ethics Committee", 
                "Germany: Ethics Commission"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Corneal staining in both eyes was assessed during slit lamp examination using flourescein dye. Each of five corneal regions (central, nasal, temporal, inferior, and superior) was graded on a scale from 0 (none) to 4 (patch). The corneal fluorescein staining score was calculated as the total of the five regions. The score ranged from 0 (no staining in any region) to 20 (patch staining in all five regions). The corneal staining of the worse eye was analyzed.", 
                "measure": "Corneal Staining", 
                "safety_issue": "No", 
                "time_frame": "Day 30"
            }, 
            {
                "description": "Corneal staining in both eyes was assessed during slit lamp examination using flourescein dye. Each of five corneal regions (central, nasal, temporal, inferior, and superior) was graded on a scale from 0 (none) to 4 (patch). The corneal fluorescein staining score was calculated as the total of the five regions. The score ranged from 0 (no staining in any region) to 20 (patch staining in all five regions). The corneal staining of the worse eye was analyzed.", 
                "measure": "Change From Baseline in Corneal Staining at Day 30", 
                "safety_issue": "No", 
                "time_frame": "Baseline (Day 0), Day 30"
            }
        ], 
        "removed_countries": {
            "country": "United States"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01684033"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Alcon Research", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Alcon Research", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}